The Globalist

Why cutting U.S. corporate taxes won’t stop a wave of offshore reincorporations.

More harmful practices by Big Pharma as U.S. sales decline and patents expire.

What are the architects of the Trans-Pacific Partnership trade agreements trying to keep secret?

How are Indian pharmaceutical firms threatening to erode Big Pharma’s dominance?

Should the U.S. pharma industry worry that the rebellion against prescription drug costs will turn into a replay of 1773?